Fanconi's anemia (FA) is a rare genetic disorder affecting children at
an early age; patients suffer from progressive bone marrow failure an
d, in many cases, from congenital malformations. as cells from FA pati
ents have an increased sensitivity to UNA-crosslinking agents, FA has
been included among the group of DNA repair disorders. However, identi
fication of a specific DNA repair defect in FA has not been firmly est
ablished, None the less, this cellular phenotype has allowed the class
ification of FA patients into eight complementation groups defining ei
ght possible FA genes. Two of these genes have now been cloned and, al
though they have raised more questions than they have answered, are fa
cilitating the identification of cellular processes implicated in the
pathophysiology of Fk, and the design of new therapies.